Massachusetts · Bill 749 · 193rd General Court

An Act relative to pharmaceutical access, costs and transparency

S 749 Sponsored by Cindy F. Friedman Died in committee

  1. Introduced Feb 16, 2023
  2. In committee Feb 16, 2023
  3. Died  
  4. Passed the House  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

By Ms. Friedman, a petition (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency. Health Care Financing.

Every action

4 steps, oldest first, as the legislature records them.

  1. CommitteeReferred to the committee on Health Care Financing · Joint Committee on Health Care Financing
  2. HouseHouse concurred
  3. CommitteeHearing rescheduled to 06/06/2023 from 10:00 AM-04:00 PM in A-2 · Joint Committee on Health Care Financing
  4. CommitteeAccompanied a new draft, see S2492 · Joint Committee on Health Care Financing

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it, joined by 14 cosponsors: 11 Democrats, 2 Republicans, 1 Independent.

All 14 cosponsors

From Massachusetts's official records (malegislature.gov/api), checked Nov 14, 2026. Text links go to the official versions; LegiList does not copy bill text.